Physician profile
Markus A Bader
NPI 1174730816
$5,151.84
in general payments reported to CMS, 2019-2025
12 companies · $3,042 in 2025
The $3,042 reported for 2025 was more than what 98% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $159 · 2022: $489 · 2023: $514 · 2024: $948 · 2025: $3,042.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,875 · Food and Beverage: $1,588 · Travel and Lodging: $40.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,875.00 |
| Food and Beverage | $1,588.45 |
| Travel and Lodging | $40.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,189.51 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Superion Indirect Decompression System |
| Nevro Corp. | $272.53 | 2022-2023 | Senza |
| Saluda Medical Americas, INC. | $182.45 | 2023-2025 | Evoke, Evoke Scs |
| Mml US, INC. | $155.08 | 2024-2025 | Reactiv8 |
| Relievant Medsystems, INC. | $144.99 | 2022 | |
| Scilex Pharmaceuticals INC. | $56.76 | 2022-2024 | |
| Medtronic, INC. | $40.29 | 2021-2023 | Kyphon Express II Kyphopak Tray |
| Averitas Pharma INC. | $34.37 | 2025 | Qutenza |
| Abbott Laboratories | $24.61 | 2023 | Octrode |
| Stryker Corporation | $20.74 | 2021 | |
| Nalu Medical, INC. | $16.48 | 2025 | Nalu Neurostimulation System |
| Almatica Pharma LLC | $14.03 | 2023 | Gralise |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Markus Bader listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.